Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 4
2005 3
2006 5
2007 11
2008 7
2009 4
2010 10
2011 17
2012 12
2013 11
2014 10
2015 8
2016 16
2017 12
2018 13
2019 10
2020 11
2021 14
2022 15
2023 17
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

182 results

Results by year

Filters applied: . Clear all
Page 1
Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial.
Lee YJ, Cho JY, You SC, Lee YH, Yun KH, Cho YH, Shin WY, Im SW, Kang WC, Park Y, Lee SY, Lee SJ, Hong SJ, Ahn CM, Kim BK, Ko YG, Choi D, Hong MK, Jang Y, Kim JS. Lee YJ, et al. Among authors: kang wc. Eur Heart J. 2023 Mar 14;44(11):972-983. doi: 10.1093/eurheartj/ehac709. Eur Heart J. 2023. PMID: 36529993 Clinical Trial.
Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease: A Post Hoc Analysis From the RACING Randomized Clinical Trial.
Lee SJ, Cha JJ, Choi WG, Lee WS, Jeong JO, Choi S, Cho YH, Park W, Yoon CH, Lee YJ, Hong SJ, Ahn CM, Kim BK, Ko YG, Choi D, Hong MK, Jang Y, Hong SJ, Kim JS; RACING Investigators. Lee SJ, et al. JAMA Cardiol. 2023 Sep 1;8(9):853-858. doi: 10.1001/jamacardio.2023.2222. JAMA Cardiol. 2023. PMID: 37531130 Clinical Trial.
Everolimus-Eluting Stents or Bypass Surgery for Multivessel Disease in Diabetics: The BEST Extended Follow-Up Study.
Kim H, Kang DY, Ahn JM, Lee J, Choi Y, Hur SH, Park HJ, Tresukosol D, Kang WC, Kwon HM, Rha SW, Lim DS, Jeong MH, Lee BK, Huang H, Lim YH, Bae JH, Kim BO, Ong TK, Ahn SG, Chung CH, Park DW, Park SJ; BEST Extended Follow-Up Study Investigators. Kim H, et al. Among authors: kang wc. JACC Cardiovasc Interv. 2023 Oct 9;16(19):2412-2422. doi: 10.1016/j.jcin.2023.07.028. JACC Cardiovasc Interv. 2023. PMID: 37821187 Clinical Trial.
Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double-blind, active-controlled, multicenter phase 3 trial.
Cho EJ, Kim MH, Kim YH, Chang K, Choi DJ, Kang WC, Shin J, Kim SH, Lee N, Son JW, Doh JH, Kim WS, Hong SJ, Rhee MY, Ahn Y, Lim SW, Hong SP, Choi SY, Hyon MS, Hwang JY, Kwon K, Cha KS, Ihm SH, Lee JH, Yoo BS, Kim HS. Cho EJ, et al. Among authors: kang wc. J Clin Hypertens (Greenwich). 2023 Sep;25(9):817-827. doi: 10.1111/jch.14707. Epub 2023 Aug 23. J Clin Hypertens (Greenwich). 2023. PMID: 37614053 Free PMC article. Clinical Trial.
Efficacy and safety of moderate-intensity statin with ezetimibe combination therapy in patients after percutaneous coronary intervention: a post-hoc analysis of the RACING trial.
Park JI, Lee SJ, Hong BK, Cho YH, Shin WY, Lim SW, Kang WC, Park Y, Lee SY, Lee YJ, Hong SJ, Ahn CM, Kim BK, Ko YG, Choi D, Hong MK, Jang Y, Kim JS; RACING investigators. Park JI, et al. Among authors: kang wc. EClinicalMedicine. 2023 Apr 4;58:101933. doi: 10.1016/j.eclinm.2023.101933. eCollection 2023 Apr. EClinicalMedicine. 2023. PMID: 37090440 Free PMC article.
Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial.
Kario K, Yokoi Y, Okamura K, Fujihara M, Ogoyama Y, Yamamoto E, Urata H, Cho JM, Kim CJ, Choi SH, Shinohara K, Mukai Y, Ikemoto T, Nakamura M, Seki S, Matoba S, Shibata Y, Sugawara S, Yumoto K, Tamura K, Yoshihara F, Nakamura S, Kang WC, Shibasaki T, Dote K, Yokoi H, Matsuo A, Fujita H, Takahashi T, Kang HJ, Sakata Y, Horie K, Inoue N, Sasaki KI, Ueno T, Tomita H, Morino Y, Nojima Y, Kim CJ, Matsumoto T, Kai H, Nanto S. Kario K, et al. Among authors: kang wc. Hypertens Res. 2022 Feb;45(2):221-231. doi: 10.1038/s41440-021-00754-7. Epub 2021 Oct 15. Hypertens Res. 2022. PMID: 34654905 Free PMC article. Clinical Trial.
Early Invasive Strategy Based on the Time of Symptom Onset of Non-ST-Segment Elevation Myocardial Infarction.
Bae S, Cha JJ, Lim S, Kim JH, Joo HJ, Park JH, Hong SJ, Yu CW, Lim DS, Kim Y, Kang WC, Cho EJ, Lee SY, Kim SW, Shin ES, Hur SH, Oh SK, Lim SH, Kim HS, Hong YJ, Ahn Y, Jeong MH, Ahn TH. Bae S, et al. Among authors: kang wc. JACC Cardiovasc Interv. 2023 Jan 9;16(1):64-75. doi: 10.1016/j.jcin.2022.09.039. JACC Cardiovasc Interv. 2023. PMID: 36599589 Free article.
Treat-to-target versus high-intensity statin treatment in patients with or without diabetes mellitus: a pre-specified analysis from the LODESTAR trial.
Lee SJ, Kang WC, Lee JY, Lee JB, Yang TH, Yoon J, Lee YJ, Hong SJ, Ahn CM, Kim JS, Kim BK, Ko YG, Choi D, Hong BK, Jang Y, Hong MK; LODESTAR Investigators. Lee SJ, et al. Among authors: kang wc. EClinicalMedicine. 2023 Sep 20;64:102227. doi: 10.1016/j.eclinm.2023.102227. eCollection 2023 Oct. EClinicalMedicine. 2023. PMID: 37767195 Free PMC article.
182 results